NEXT
Sign in to follow

The Legal Intelligencer

Blockchain Technology—Patent Eligible Subject Matter or Just a Business Model?

Bitcoin, Ethereum and Litecoin have become household terms. Bitcoin's unprecedented run to $20,000 (and back down again), along with similarly impressive gains by other cryptocurrency, has created a horde of so called crypto-millionaires.
8 minute read

National Law Journal

Ariz. Jury Awards $3.6M in First Bellwether Trial of Bard IVC Blood Filters

A federal jury in Arizona's verdict included $2 million in punitive damages against the makers of an implanted blood filter that broke apart and left fragments in a woman's heart and lodged in her artery. More than 3,000 suits have been filed against C.R. Bard over the devices.
3 minute read

The Legal Intelligencer

IP Protection and the Cannabis Industry: Strategies and Trends

Protection of intellectual property is a key element in any company's efforts to secure a competitive advantage.
9 minute read

Corporate Counsel

AcelRx Hires New GC From McKesson Corp. Before Resubmitting Pain Drug to FDA

AcelRx Pharmaceuticals Inc. has hired John Saia, most recently associate general counsel at drug distributor McKesson Corp., as its new top lawyer.
2 minute read

The American Lawyer

How Boston Became a Beacon on the Hill to Big Law

As Boston undergoes a renaissance, law firms are being drawn to its shores, ready to capitalize on a booming market.
8 minute read

The Legal Intelligencer

Coast-to-Coast Effects of a 'Heartland' Case

May 22, 2017, was a game-changing day for patent litigators across the United States, albeit a day that many experts assumed was coming.
8 minute read

Delaware Business Court Insider

Investor Lawsuit Against Venture Capital Firm Over Control of Medical Device Company Clears Hurdle

New Enterprise Associates Inc. cannot escape a shareholder lawsuit accusing the venture capital giant of exploiting its control of a medical device company in order to secure other deals for its own benefit, the Delaware Court of Chancery has ruled.
4 minute read

The Legal Intelligencer

$40M From Pharma Inventor's Licensing Contracts Is Taxable as Income, Not Capital Gain

Millions of dollars a pharmaceutical inventor received under a technology license agreement should be treated as ordinary income, rather than capital gains, for tax purposes, a split federal appeals panel has ruled.
3 minute read

Corporate Counsel

Merck & Co. Names Covington's Jennifer Zachary as New General Counsel

A partner in Covington & Burling's food, drug, and device practice group and a former associate chief counsel for enforcement in the U.S. Food and Drug Administration's Office of Chief Counsel is named GC at the pharmaceutical giant.
4 minute read

Corporate Counsel

Pain Pharma Company Collegium Brings Outside Counsel In-House as Its First GC

Canton, Massachusetts-based Collegium Pharmaceutical has hired Shirley Kuhlmann as the pain management pharmaceutical company's first executive vice president, general counsel and secretary.
2 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Aligning Client Needs with Lawyer Growth and Profitability

    Brought to you by BigHand

    Download Now

  • Technology to Make E-Discovery Smarter, Not Harder

    Brought to you by Nuix

    Download Now

  • Does Generative AI Have the Power to Transform Legal Services?

    Brought to you by HaystackID

    Download Now

  • How This Personal Injury Firm Reduced Client Intake Time by 80%

    Brought to you by PracticePanther

    Download Now